Multiple sclerosis

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

Abstract

Multiple sclerosis (MS) affects approximately 2.5 million individuals worldwide. The prevalence of MS varies considerably across the world, the highest prevalence being in North America and Europe, and lowest in East Asia and sub-Saharan Africa. While the specific cause(s) of MS are largely unknown, they likely involve a complex interaction of genetic and environmental factors. Individuals with an affected first-degree relative have a 2–4% risk of developing MS, compared to a 0.1% risk in the general population. For most individuals, the major source of vitamin D is sunlight exposure. As duration and intensity of sunlight are strongly linked to latitude, the higher incidence of MS at higher latitudes has been proposed to reflect vitamin D deficiency. MS is characterised by the complex interplay of immunological and neurodegenerative processes, culminating in heterogeneity in the clinical course and symptom expression. Cortical pathology is a frequent phenomenon in MS, and observed in all stages of the disease.
Original languageEnglish
Title of host publicationDegenerative Disorders of the Brain
EditorsDarren R. Hocking, John L. Bradshaw, Joanne Fielding
Place of PublicationOxon UK
PublisherRoutledge
Chapter7
Pages163-185
Number of pages23
Edition1st
ISBN (Electronic)9781351208918
ISBN (Print)9780815382249, 9780815382263
DOIs
Publication statusPublished - 22 Apr 2019

Cite this

Fielding, J., & Clough, M. (2019). Multiple sclerosis. In D. R. Hocking, J. L. Bradshaw, & J. Fielding (Eds.), Degenerative Disorders of the Brain (1st ed., pp. 163-185). Routledge. https://doi.org/10.4324/9781351208918-7